Abstract
4-Methylpyrazole, in a dose producing inhibition of alcohol dehydrogenase (alcohol:NAD+ oxidoreductase, EC 1.1.1.1), was given alone or together with ethanol (10%) as sole drinking fluid to growing rats for up to 38 weeks. Their weight curves remained normal. Electron microscopy of liver, kidney, and heart revealed no changes related to treatment. Hematologic analysis showed normal values for blood and bone marrow. Several clinical chemical parameters showed no impairment of liver or kidney function, except for an enhancement of the microsomal drug-metabolizing activity after concurrent administration of 4-methylpyrazole and ethanol. A study on rats receiving 4-methylpyrazole and ethanol indicated a mutual interaction of the two compounds or the metabolites, leading to increased concentration in the blood of the compounds and reduced formation of 4-hydroxymethylpyrazole, the primary metabolite of 4-methylpyrazole. In monkeys, elimination of 4-methylpyrazole followed a linear course. 4-Hydroxymethylpyrazole accumulated to a level of at most 10% of that of 4-methylpyrazole. Concurrent administration of methanol inhibited the elimination of 4-methylpyrazole about 25%, and 4-methylpyrazole produced a profound inhibition of the oxidation of methanol. 4-Methylpyrazole, at a level in the plasma of more than 10 μM, prevented accumulation of the toxic metabolite formic acid in methanol-poisoned monkeys, and repeated injections of 4-methylpyrazole abolished methanol toxicity in monkeys receiving lethal doses of methanol. The present investigation indicates that 4-methylpyrazole, with its low toxicity and strong inhibition of alcohol oxidation, is a valuable tool for experimental studies of alcohol metabolism and its effects. It illustrates the usefulness of the monkey as a model to study 4-methylpyrazole activity and toxicity in light of its possible use for treating methanol poisoning in human beings.
Keywords: methylpyrazole metabolism and toxicity, alcohol—methylpyrazole interaction
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- BENNETT I. L., Jr, CARY F. H., MITCHELL G. L., Jr, COOPER M. N. Acute methyl alcohol poisoning: a review based on experiences in an outbreak of 323 cases. Medicine (Baltimore) 1953 Dec;32(4):431–463. doi: 10.1097/00005792-195312000-00002. [DOI] [PubMed] [Google Scholar]
- Björkhem I., Blomstrand R., Lantto O., Svensson L. Determination of 4-methylpyrozol in serum with mass fragmentography. Biochem Med. 1975 Mar;12(3):205–212. doi: 10.1016/0006-2944(75)90122-2. [DOI] [PubMed] [Google Scholar]
- Björkhem I., Blomstrand R., Lantto O., Svensson L., Ohman G. Toward absolute methods in clinical chemistry: application of mass fragmentography to high-accuracy analyses. Clin Chem. 1976 Nov;22(11):1789–1801. [PubMed] [Google Scholar]
- Blomstrand R., Kager L. The combustion of triolein-1-14C and its inhibiton by alcohol in man. Life Sci. 1973 Jul 16;13(2):113–123. doi: 10.1016/0024-3205(73)90186-0. [DOI] [PubMed] [Google Scholar]
- Blomstrand R., Löf A., Ostling H. Studies on the metabolic effects of long-term administration of ethanol and 4-methylpyrazole in the rat. Vitamin A depletion in the liver. Nutr Metab. 1977;21 (Suppl 1):148–151. [PubMed] [Google Scholar]
- Blomstrand R., Ohman G. Studies on the metabolism of LADH-inhibitor 4-methylpyrazole in the rat. Life Sci. 1973 Jul 16;13(2):107–112. doi: 10.1016/0024-3205(73)90185-9. [DOI] [PubMed] [Google Scholar]
- Blomstrand R., Theorell H. Inhibitory effect on ethanol oxidation in man after administration of 4-methylpyrazole. Life Sci II. 1970 Jun 8;9(11):631–640. doi: 10.1016/0024-3205(70)90214-6. [DOI] [PubMed] [Google Scholar]
- Engfeldt B., Brunius E. Morphological effects of rapeseed oil in rats. II. Long-term studies. Acta Med Scand Suppl. 1975;585:27–40. doi: 10.1111/j.0954-6820.1975.tb06556.x. [DOI] [PubMed] [Google Scholar]
- Kager L., Ericsson J. L. Long term toxicity study with alcohol and 4-methylpyrazole in rat. Acta Pathol Microbiol Scand A. 1974 Jul;82(4):534–538. doi: 10.1111/j.1699-0463.1974.tb00383.x. [DOI] [PubMed] [Google Scholar]
- Lelbach W. K. Liver cell necrosis in rats after prolonged ethanol ingestion under the influence of an alcohol-dehydrogenase inhibitor. Experientia. 1969 Aug 15;25(8):816–818. doi: 10.1007/BF01897894. [DOI] [PubMed] [Google Scholar]
- Lester D., Keokosky W. Z., Felzenberg F. Effect of pyrazoles and other compounds on alcohol metabolism. Q J Stud Alcohol. 1968 Jun;29(2):449–454. [PubMed] [Google Scholar]
- Li T. K., Theorell H. Human liver alcohol dehydrogenase: inhibition by pyrazole and pyrazole analogs. Acta Chem Scand. 1969;23(3):892–902. doi: 10.3891/acta.chem.scand.23-0892. [DOI] [PubMed] [Google Scholar]
- Lieber C. S., Rubin E., DeCarli L. M., Misra P., Gang H. Effects of pyrazole on hepatic function and structure. Lab Invest. 1970 Jun;22(6):615–621. [PubMed] [Google Scholar]
- Magnusson G., Nyberg J. A., Bodin N. O., Hansson E. Toxicity of pyrazole and 4-methylpyrazole in mice and rats. Experientia. 1972 Oct 15;28(10):1198–1200. doi: 10.1007/BF01946169. [DOI] [PubMed] [Google Scholar]
- Makar A. B., McMartin K. E., Palese M., Tephly T. R. Formate assay in body fluids: application in methanol poisoning. Biochem Med. 1975 Jun;13(2):117–126. doi: 10.1016/0006-2944(75)90147-7. [DOI] [PubMed] [Google Scholar]
- Makar A. B., Tephly T. R. Inhibition of monkey liver alcohol dehydrogenase by 4-methylpyrazole. Biochem Med. 1975 Aug;13(4):334–342. doi: 10.1016/0006-2944(75)90172-6. [DOI] [PubMed] [Google Scholar]
- Martin-Amat G., McMartin K. E., Hayreh S. S., Hayreh M. S., Tephly T. R. Methanol poisoning: ocular toxicity produced by formate. Toxicol Appl Pharmacol. 1978 Jul;45(1):201–208. doi: 10.1016/0041-008x(78)90040-6. [DOI] [PubMed] [Google Scholar]
- McMartin K. E., Makar A. B., Martin G., Palese M., Tephly T. R. Methanol poisoning. I. The role of formic acid in the development of metabolic acidosis in the monkey and the reversal by 4-methylpyrazole. Biochem Med. 1975 Aug;13(4):319–333. doi: 10.1016/0006-2944(75)90171-4. [DOI] [PubMed] [Google Scholar]
- Pietruszko R. Human liver alcohol dehydrogenase--inhibition of methanol activity by pyrazole, 4-methylpyrazole, 4-hydroxymethylpyrazole and 4-carboxypyrazole. Biochem Pharmacol. 1975 Sep 1;24(17):1603–1607. doi: 10.1016/0006-2952(75)90087-8. [DOI] [PubMed] [Google Scholar]
- Posner H. S. Biohazards of methanol in proposed new uses. J Toxicol Environ Health. 1975 Sep;1(1):153–171. doi: 10.1080/15287397509529315. [DOI] [PubMed] [Google Scholar]
- Rydberg U., Neri A. 4-Methylpyrazole as an inhibitor of ethanol metabolism: differential metabolic and central nervous effects. Acta Pharmacol Toxicol (Copenh) 1972;31(5):421–432. doi: 10.1111/j.1600-0773.1972.tb03605.x. [DOI] [PubMed] [Google Scholar]
- Salaspuro M. P., Lindros K. O., Pikkarainen P. H. Effect of 4-methylpyrazole on ethanol elimination rate and hepatic redox changes in alcoholics with adequate or inadequate nutrition and in nonalcoholic controls. Metabolism. 1978 Jun;27(6):631–639. doi: 10.1016/0026-0495(78)90001-x. [DOI] [PubMed] [Google Scholar]
- Salaspuro M. P., Pikkarainen P., Lindros K. Ethanol-induced hypoglycaemia in man: its suppression by the alcohol dehydrogenase inhibitor 4-methylpyrazole. Eur J Clin Invest. 1977 Dec;7(6):487–490. doi: 10.1111/j.1365-2362.1977.tb01640.x. [DOI] [PubMed] [Google Scholar]
- Składziński J., Beskid M. Combined action of pyrazole and ethanol on a rat liver: histochemical and ultrastructural study. Folia Histochem Cytochem (Krakow) 1978;16(1):13–18. [PubMed] [Google Scholar]
- THEORELL H., YONETANI T. LIVER ALCOHOL DEHYDROGENASE-DPN-PYRAZOLE COMPLEX: A MODEL OF A TERNARY INTERMEDIATE IN THE ENZYME REACTION. Biochem Z. 1963;338:537–553. [PubMed] [Google Scholar]
- Watkins W. D., Goodman J. I., Tephly T. R. Inhibition of methanol and ethanol oxidation by pyrazole in the rat and monkey in vivo. Mol Pharmacol. 1970 Sep;6(5):567–572. [PubMed] [Google Scholar]